We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Full Spectrum Endoscopy Reduces “Miss Rate” of Adenomas

By HospiMedica International staff writers
Posted on 30 May 2013
A wide-field endoscopy system significantly improves the accuracy of adenoma detection during colonoscopy procedures. More...


The EndoChoice (Atlanta, GA, USA) Fuse system is a proprietary arrangement of three small cameras at the tip of a flexible gastrointestinal (GI) endoscope. By using three cameras, the system allows doctors to see nearly twice as much surface area as they can with traditional endoscopes, since the wider angles allow examination of folds that occur naturally in the colon and stomach anatomy, problem areas that can easily go undetected when using traditional one-camera endoscopes.

In a study conducted by researchers at the Israel Institute of Technology (Technion; Haifa, Israel) and other institutions, researchers compared traditional endoscopes to the Fuse system. The endoscope used in the first examination was selected randomly, and the patient immediately underwent a second colonoscopy performed by the same doctor with the Fuse endoscope. The 185 patient trial showed traditional colonoscopes missed 42% of adenomas, while the Fuse system missed just 8%, reflecting an incremental find rate of 71%. The study was presented at Digestive Disease Week (DDW), held during May 2013 in Orlando (FL, USA).

“Traditional endoscopes provide up to 170° of forward vision. The advantage of Fuse is that it allows endoscopists to examine twice the anatomy with a wide 330° view,” said study presenter Ian Gralnek, MD, of the Technion. “Our findings are compelling and support the data from previous studies showing the limitations of traditional endoscopes. EndoChoice's innovative Fuse technology dramatically improves the effectiveness of this life-saving procedure.”

“Since we announced the expansion of our company in January, our teams in Israel, Germany, and the United States have been working diligently to develop and launch the revolutionary Fuse endoscopy system,” said Mark Gilreath, Founder and CEO of EndoChoice, commenting on the Fuse system receiving the approval of the US Food and Drug Administration (FDA), announced during DDW 2013.

Related Links:

EndoChoice
Israel Institute of Technology



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Vessel Sealing Instrument
ERGOseal
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.